These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16730688)

  • 21. Extracellular regucalcin suppresses colony formation and growth independent of tumor suppressor p53 in human mammary epithelial cells.
    Yamaguchi M; Murata T
    Tissue Cell; 2020 Dec; 67():101447. PubMed ID: 33137709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitomycin C and doxorubicin elicit conflicting signals by causing accumulation of cyclin E prior to p21WAF1/CIP1 elevation in human hepatocellular carcinoma cells.
    Choi SY; Shen YN; Woo SR; Yun M; Park JE; Ju YJ; Jeong J; Shin HJ; Joo HY; Park ER; Lee JK; Kim SH; Cho MH; Kong IS; Lee KH
    Int J Oncol; 2012 Jan; 40(1):277-86. PubMed ID: 21887464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural and functional consequences of inactivation of human glutathione S-transferase P1-1 mediated by the catechol metabolite of equine estrogens, 4-hydroxyequilenin.
    Chang M; Shin YG; van Breemen RB; Blond SY; Bolton JL
    Biochemistry; 2001 Apr; 40(15):4811-20. PubMed ID: 11294649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations.
    Delia D; Goi K; Mizutani S; Yamada T; Aiello A; Fontanella E; Lamorte G; Iwata S; Ishioka C; Krajewski S; Reed JC; Pierotti MA
    Oncogene; 1997 May; 14(18):2137-47. PubMed ID: 9174049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Equine catechol estrogen 4-hydroxyequilenin is a more potent inhibitor of the variant form of catechol-O-methyltransferase.
    Li Y; Yao J; Chang M; Nikolic D; Yu L; Yager JD; Mesecar AD; van Breemen RB; Bolton JL
    Chem Res Toxicol; 2004 Apr; 17(4):512-20. PubMed ID: 15089093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human mammary epithelial cells exhibit a differential p53-mediated response following exposure to ionizing radiation or UV light.
    Meyer KM; Hess SM; Tlsty TD; Leadon SA
    Oncogene; 1999 Oct; 18(42):5795-805. PubMed ID: 10523860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of estrogen receptor-mediated gene transcription by the equine estrogen metabolite, 4-methoxyequilenin, in human breast cancer cells.
    Chang M; Peng KW; Kastrati I; Overk CR; Qin ZH; Yao P; Bolton JL; Thatcher GR
    Endocrinology; 2007 Oct; 148(10):4793-802. PubMed ID: 17584965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
    Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Equine estrogen metabolite 4-hydroxyequilenin induces DNA damage in the rat mammary tissues: formation of single-strand breaks, apurinic sites, stable adducts, and oxidized bases.
    Zhang F; Swanson SM; van Breemen RB; Liu X; Yang Y; Gu C; Bolton JL
    Chem Res Toxicol; 2001 Dec; 14(12):1654-9. PubMed ID: 11743748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the environmental mammary carcinogen 6-nitrochrysene on p53 and p21(Cip1) protein expression and cell cycle regulation in MCF-7 and MCF-10A cells.
    Sun YW; Herzog CR; Krzeminski J; Amin S; Perdew G; El-Bayoumy K
    Chem Biol Interact; 2007 Oct; 170(1):31-9. PubMed ID: 17678638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nature of G1/S cell cycle checkpoint defect in ataxia-telangiectasia.
    Khanna KK; Beamish H; Yan J; Hobson K; Williams R; Dunn I; Lavin MF
    Oncogene; 1995 Aug; 11(4):609-18. PubMed ID: 7651723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
    Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
    Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cell cycle regulation after exposure to ionizing radiation].
    Teyssier F; Bay JO; Dionet C; Verrelle P
    Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA damage and p53 induction do not cause ZD1694-induced cell cycle arrest in human colon carcinoma cells.
    Matsui SI; Arredondo MA; Wrzosek C; Rustum YM
    Cancer Res; 1996 Oct; 56(20):4715-23. PubMed ID: 8840989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of p53-independent p21 during ceramide-induced G1 arrest in human hepatocarcinoma cells.
    Kim WH; Kang KH; Kim MY; Choi KH
    Biochem Cell Biol; 2000; 78(2):127-35. PubMed ID: 10874474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a liquid chromatography electrospray ionization tandem mass spectrometry method for analysis of stable 4-hydroxyequilenin-DNA adducts in human breast cancer cells.
    Wang Z; Edirisinghe P; Sohn J; Qin Z; Geacintov NE; Thatcher GR; Bolton JL
    Chem Res Toxicol; 2009 Jun; 22(6):1129-36. PubMed ID: 19368368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NMR and computational studies of stereoisomeric equine estrogen-derived DNA cytidine adducts in oligonucleotide duplexes: opposite orientations of diastereomeric forms.
    Zhang N; Ding S; Kolbanovskiy A; Shastry A; Kuzmin VA; Bolton JL; Patel DJ; Broyde S; Geacintov NE
    Biochemistry; 2009 Aug; 48(30):7098-109. PubMed ID: 19527068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attenuated response of p53 and p21 in primary cultures of human prostatic epithelial cells exposed to DNA-damaging agents.
    Girinsky T; Koumenis C; Graeber TG; Peehl DM; Giaccia AJ
    Cancer Res; 1995 Sep; 55(17):3726-31. PubMed ID: 7543816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quinacrine has anticancer activity in breast cancer cells through inhibition of topoisomerase activity.
    Preet R; Mohapatra P; Mohanty S; Sahu SK; Choudhuri T; Wyatt MD; Kundu CN
    Int J Cancer; 2012 Apr; 130(7):1660-70. PubMed ID: 21544805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suramin increases p53 protein levels but does not activate the p53-dependent G1 checkpoint.
    Howard SP; Park SJ; Hughes-Davies L; Coleman CN; Price BD
    Clin Cancer Res; 1996 Feb; 2(2):269-76. PubMed ID: 9816169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.